RT Journal Article
SR Electronic
T1 COVID-19 Acceleration and Vaccine Status in France - August 2021
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.18.21263773
DO 10.1101/2021.09.18.21263773
A1 Baunez, Christelle
A1 Degoulet, Mickael
A1 Luchini, Stéphane
A1 Pintus, Patrick A.
A1 Teschl, Miriam
YR 2021
UL http://medrxiv.org/content/early/2021/09/22/2021.09.18.21263773.abstract
AB Objectives This note provides an assessment of COVID-19 acceleration among groups with difference vaccine status in France.Methods We assess viral acceleration using a novel indicator introduced in Baunez et al. (2021). The acceleration index relates the percentage change of tests that have been performed on a given day to the percentage change in the associated positive cases that same day. We compare viral acceleration among vaccinated and unvaccinated individuals in France over the period May 31st - August 29, 2021.Results Once the state of the epidemic within each groups is accounted for, it turns out that viral acceleration has since mid-July converged to similar levels among vaccinated and unvaccinated individuals in France, even though viral speed is larger for the latter group compared to the former.Conclusion Our results call for an increasing testing effort for both vaccinated and unvaccinated individuals, in view of the fact that viral circulation is currently accelerating at similar levels for both groups in France.JEL Classification Numbers I18; H12Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in this note are available at https://data.drees.solidarites-sante.gouv.fr/explore/dataset/ covid-19-resultats-issus-des-appariements-entre-si-vic-si-dep-et-vac-si/information/?disjunctive. vac_statut, accessed August 22, 2021. https://data.drees.solidarites-sante.gouv.fr/explore/dataset/covid-19-resultats-issus-des-appariements-entre-si-vic-si-dep-et-vac-si/information/?disjunctive.vac_statut